Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001781193 | SCV002017183 | pathogenic | not provided | 2019-03-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496285 | SCV002781293 | pathogenic | Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Exudative vitreoretinopathy 1; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Osteoporosis; Polycystic liver disease 4 with or without kidney cysts | 2022-03-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001781193 | SCV003924865 | pathogenic | not provided | 2022-11-11 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35383688, 11719191, 33707600, 16390319, 16252235) |
OMIM | RCV000006647 | SCV000026830 | pathogenic | Osteoporosis with pseudoglioma | 2001-11-16 | no assertion criteria provided | literature only | |
Prevention |
RCV003904811 | SCV004727538 | pathogenic | LRP5-related disorder | 2023-12-05 | no assertion criteria provided | clinical testing | The LRP5 c.1282C>T variant is predicted to result in premature protein termination (p.Arg428*). This variant was reported in a homozygous individual presenting with Osteoporosis-pseudoglioma syndrome (Figure 2A, Gong et al 2001. PubMed ID: 11719191). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in LRP5 are expected to be pathogenic. This variant is interpreted as pathogenic. |